甲状腺肿块评估

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133.全文  摘要

Gharib H, Papini E, Garber JR, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.全文  摘要

Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015 Jun;25(6):567-610.全文  摘要

Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015 Jul;25(7):716-59.全文  摘要

Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017 May;14(5):587-95.全文  摘要

1. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2016 Jan;26(1):1-133.全文  摘要

2. Gharib H, Papini E, Garber JR, et al. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI medical guidelines for clinical practice for the diagnosis and management of thyroid nodules - 2016 update. Endocr Pract. 2016 May;22(5):622-39.全文  摘要

3. Alexander EK, Cibas ES. Diagnosis of thyroid nodules. Lancet Diabetes Endocrinol. 2022 Jul;10(7):533-9. 摘要

4. Sajisevi M, Caulley L, Eskander A, et al. Evaluating the rising incidence of thyroid cancer and thyroid nodule detection modes: a multinational, multi-institutional analysis. JAMA Otolaryngol Head Neck Surg. 2022 Sep 1;148(9):811-8.全文  摘要

5. La Vecchia C, Malvezzi M, Bosetti C, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015 May 1;136(9):2187-95.全文  摘要

6. Kwong N, Medici M, Angell TE, et al. Thyroid nodule evaluation and management in older adults: a review of practical considerations for clinical endocrinologists. J Clin Endocrinol Metab. 2015 Dec;100(12):4434-40. 摘要

7. Ospina NS, Papaleontiou M. Thyroid Nodule Evaluation and Management in Older Adults: A Review of Practical Considerations for Clinical Endocrinologists. Endocr Pract. 2021 Mar;27(3):261-268.全文  摘要

8. MORTENSEN JD, WOOLNER LB, BENNETT WA. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab. 1955 Oct;15(10):1270-80. 摘要

9. Singh Ospina N, Iñiguez-Ariza NM, Castro MR. Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment. BMJ. 2020 Jan 7;368:l6670. 摘要

10. Wiersinga WM, Poppe KG, Effraimidis G. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. Lancet Diabetes Endocrinol. 2023 Apr;11(4):282-98. 摘要

11. Megwalu UC, Moon PK. Thyroid cancer incidence and mortality trends in the United States: 2000-2018. Thyroid. 2022 May;32(5):560-70. 摘要

12. Wells SA Jr, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015 Jun;25(6):567-610.全文  摘要

13. Waguespack SG, Rich TA, Perrier ND, et al. Management of medullary thyroid carcinoma and MEN2 syndromes in childhood. Nat Rev Endocrinol. 2011 Aug 23;7(10):596-607. 摘要

14. Bible KC, Kebebew E, Brierley J, et al. 2021 American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2021 Mar;31(3):337-86.全文  摘要

15. Zhu Y, Yang S, He X. Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort. J Endocrinol Invest. 2022 Apr;45(4):815-24.全文  摘要

16. de los Santos ET, Keyhani-Rofagha S, Cunningham JJ, et al. Cystic thyroid nodules: the dilemma of malignant lesions. Arch Intern Med. 1990 Jul;150(7):1422-7. 摘要

17. Jasim S, Patel KN, Randolph G, et al. American Association of Clinical Endocrinology Disease State clinical review: the clinical utility of minimally invasive interventional procedures in the management of benign and malignant thyroid lesions. Endocr Pract. 2022 Apr;28(4):433-48. 摘要

18. Garber JR, Papini E, Frasoldati A, et al. American Association of Clinical Endocrinology and Associazione Medici Endocrinologi thyroid nodule algorithmic tool. Endocr Pract. 2021 Jul;27(7):649-60.全文  摘要

19. Hong HS, Lee JY, Jeong SH. Thyroid disease in children and adolescents. Ultrasonography. 2017 Oct;36(4):289-91.全文  摘要

20. Lafontaine N, Learoyd D, Farrel S, et al. Suppurative thyroiditis: Systematic review and clinical guidance. Clin Endocrinol (Oxf). 2021 Aug;95(2):253-264.全文  摘要

21. Stasiak M, Lewiński A. New aspects in the pathogenesis and management of subacute thyroiditis. Rev Endocr Metab Disord. 2021 Dec;22(4):1027-39.全文  摘要

22. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf). 1995 Jul;43(1):55-68. 摘要

23. Rothman IN, Middleton L, Stack BC Jr, et al. Incidence of diffuse FDG uptake in the thyroid of patients with hypothyroidism. Eur Arch Otorhinolaryngol. 2011 Oct;268(10):1501-4. 摘要

24. Jiang W, Lu G, Gao D, et al. The relationships between the gut microbiota and its metabolites with thyroid diseases. Front Endocrinol (Lausanne). 2022;13:943408.全文  摘要

25. Mikulska AA, Karaźniewicz-Łada M, Filipowicz D, et al. Metabolic characteristics of Hashimoto's thyroiditis patients and the role of microelements and diet in the disease management-an overview. Int J Mol Sci. 2022 Jun 13;23(12).全文  摘要

26. Danailova Y, Velikova T, Nikolaev G, et al. Nutritional management of thyroiditis of Hashimoto. Int J Mol Sci. 2022 May 5;23(9).全文  摘要

27. Samuels MH. Subacute, silent, and postpartum thyroiditis. Med Clin North Am. 2012 Mar;96(2):223-33. 摘要

28. Shi HH, McHenry CR. Coexistent thyroid nodules in patients with graves' disease: What is the frequency and the risk of malignancy? Am J Surg. 2018 Nov;216(5):980-4. 摘要

29. Staniforth JUL, Erdirimanne S, Eslick GD. Thyroid carcinoma in Graves' disease: A meta-analysis. Int J Surg. 2016 Mar;27:118-25.全文  摘要

30. Expert Panel on Neurological Imaging, Zander D, Bunch PM, et al. ACR appropriateness criteria® parathyroid adenoma. J Am Coll Radiol. 2021 Nov;18(11s):S406-22.全文  摘要

31. Fingeret AL. Contemporary evaluation and management of parathyroid carcinoma. JCO Oncol Pract. 2021 Jan;17(1):17-21.全文  摘要

32. Tang Q, Wang Z. Metastases to the thyroid gland: what can we do? Cancers (Basel). 2022 Jun 19;14(12).全文  摘要

33. American College of Radiology. ACR–AIUM–SPR–SRU practice parameter for the performance and interpretation of diagnostic ultrasound of the thyroid and extracranial head and neck. 2022 [internet publication].全文

34. National Institute for Health and Care Excellence. Thyroid cancer: assessment and management. Dec 2022 [internet publication].​全文

35. Durante C, Hegedüs L, Czarniecka A, et al. 2023 European Thyroid Association cinical practice guidelines for thyroid nodule management. Eur Thyroid J. 2023 Oct 1;12(5).全文  摘要

36. Agrawal K, Weaver J, Ngu R, et al. Clinical significance of patterns of incidental thyroid uptake at (18)F-FDG PET/CT. Clin Radiol. 2015 May;70(5):536-43. 摘要

37. Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015 Jul;25(7):716-59.全文  摘要

38. National Institute for Health and Care Excellence. Thyroid disease: assessment and management. Oct 2023 [internet publication].全文

39. Hegedüs L. Clinical practice: the thyroid nodule. N Engl J Med. 2004 Oct 21;351(17):1764-71. 摘要

40. Maher DI, Goare S, Forrest E, et al. Routine preoperative laryngoscopy for thyroid surgery is not necessary without risk factors. Thyroid. 2019 Nov;29(11):1646-52. 摘要

41. Pynnonen MA, Gillespie MB, Roman B, et al. Clinical practice guideline: evaluation of the neck mass in adults. Otolaryngol Head Neck Surg. 2017 Sep;157(2 Suppl):S1-30. 摘要

42. Samarasinghe S, Meah F, Singh V, et al. Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks. Endocr Pract. 2017 Aug;23(8):989-98. 摘要

43. Li D, Ferguson A, Cervinski MA, et al. AACC guidance document on biotin interference in laboratory tests. J Appl Lab Med. 2020 May 1;5(3):575-87.全文  摘要

44. Verbeek HH, de Groot JWB, Sluiter WJ, et al. Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules. Cochrane Database Syst Rev. 2020 Mar 16;3(3):CD010159.全文  摘要

45. Tessler FN, Middleton WD, Grant EG, et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017 May;14(5):587-95.全文  摘要

46. Khalid AN, Hollenbeak CS, Quraishi SA, et al. The cost-effectiveness of iodine 131 scintigraphy, ultrasonography, and fine-needle aspiration biopsy in the initial diagnosis of solitary thyroid nodules. Arch Otolaryngol Head Neck Surg. 2006 Mar;132(3):244-50.全文  摘要

47. Hales NW, Krempl GA, Medina JE. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am J Otolaryngol. 2008 Mar-Apr;29(2):113-8. 摘要

48. Piek MW, de Boer JP, Vriens MR, et al. Retrospective analyses of (18)FDG-PET/CT thyroid incidentaloma in adults: incidence, treatment, and outcome in a tertiary cancer referral center. Thyroid. 2021 Nov;31(11):1715-22. 摘要

49. Ayan A, Basaran Y, Kirnap NG, et al. Synchronous thyroid cancer on the edge: incidentalomas of 18F-FDG PET/CT in clinical practice. Niger J Clin Pract. 2021 Jun;24(6):937-42. 摘要

50. Adas M, Adas G, Koc B, et al. Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management. Minerva Endocrinol. 2015 Sep;40(3):169-75. 摘要

51. Boeckmann J, Bartel T, Siegel E, et al. Can the pathology of a thyroid nodule be determined by positron emission tomography uptake? Otolaryngol Head Neck Surg. 2012 Jun;146(6):906-12. 摘要

52. Park JY, Choi W, Hong AR, et al. A comprehensive assessment of the harms of fine-needle aspiration biopsy for thyroid nodules: a systematic review. Endocrinol Metab (Seoul). 2023 Feb;38(1):104-16.全文  摘要

53. Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am. 2007 Sep;36(3):707-35. 摘要

54. Cesur M, Corapcioglu D, Bulut S, et al. Comparison of palpation-guided fine-needle aspiration biopsy to ultrasound-guided fine-needle aspiration biopsy in the evaluation of thyroid nodules. Thyroid. 2006 Jun;16(6):555-61. 摘要

55. Theoharis CG, Schofield KM, Hammers L, et al. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid. 2009 Nov;19(11):1215-23. 摘要

56. Jo VY, Stelow EB, Dustin SM, et al. Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2010 Sep;134(3):450-6. 摘要

57. Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid. 2017 Nov;27(11):1341-6.全文  摘要

58. Bumpous J, Celestre MD, Pribitkin E, et al. Decision making for diagnosis and management: algorithms from experts for molecular testing. Otolaryngol Clin North Am. 2014 Aug;47(4):609-23. 摘要

59. Alexander EK, Heering JP, Benson CB, et al. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. J Clin Endocrinol Metab. 2002 Nov;87(11):4924-7.全文  摘要

60. Chehade JM, Silverberg AB, Kim J, et al. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. Endocr Pract. 2001 Jul-Aug;7(4):237-43. 摘要

61. Baloch ZW, Cibas ES, Clark DP, et al. The National Cancer Institute Thyroid fine needle aspiration state of the science conference: a summation. Cytojournal. 2008 Apr 7;5:6.全文  摘要

62. British Thyroid Association. Guidelines for the management of thyroid cancer. July 2014 [internet publication].全文

63. Nishino M, Nikiforova M. Update on molecular testing for cytologically indeterminate thyroid nodules. Arch Pathol Lab Med. 2018 Apr;142(4):446-57.全文  摘要

64. Hu MI, Waguespack SG, Dosiou C, et al. Afirma Genomic Sequencing Classifier and Xpression Atlas molecular findings in consecutive Bethesda III-VI thyroid nodules. J Clin Endocrinol Metab. 2021 Jul 13;106(8):2198-207.全文  摘要

65. McCoy KL, Jabbour N, Ogilvie JB, et al. The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size. Surgery. 2007 Dec;142(6):837-44. 摘要

66. Kim DH, Kim SW, Basurrah MA, et al. Diagnostic performance of six ultrasound risk stratification systems for thyroid nodules: a systematic review and network meta-analysis. AJR Am J Roentgenol. 2023 Jun;220(6):791-803.全文  摘要

67. Peixoto R, Correia Pinto J, Soares V, et al. Primary thyroid lymphoma: A case report and review of the literature. Ann Med Surg (Lond). 2017 Jan;13:29-33.全文  摘要

68. Pedersen IB, Knudsen N, Perrild H, et al. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clin Endocrinol (Oxf). 2001 Sep;55(3):381-90. 摘要